Literature DB >> 20972366

The benefit of small bowel and pelvic bone sparing in excluding common iliac lymph node region from conventional radiation fields in patients with uterine cervical cancer: a dosimetric study.

Takahiro Oike1, Tatsuya Ohno, Masaru Wakatsuki, Shin-ei Noda, Jun-ichi Saitoh, Tatsuji Mizukami, Yuya Yoshimoto, Noriyuki Okonogi, Hiroyuki Katoh, Kei Shibuya, Yoshiyuki Suzuki, Hitoshi Ishikawa, Takeshi Ebara, Takeo Takahashi, Takashi Nakano.   

Abstract

The purpose of this study was to compare dose reduction to the small bowel and sacral bone by two-field and four-field techniques when the common iliac lymph node region is excluded from the radiation field in external beam radiotherapy of uterine cervical cancer. Thirteen patients with cervical cancer were entered into the study. Conventional treatment plans based on bony landmarks were made with parallel-opposed two-field technique (C2F) and four-field box technique (C4F). Modified C2F (M2F) and C4F (M4F) plans of excluding the common iliac lymph node region from the conventional radiation fields were created in reference to the bifurcations of pelvic arteries in computed tomography images. For each patient, the dose volume histograms for the small bowel and sacral bone resulting from the C2F, C4F, M2F, and M4F plans were compared. The volumes were obtained at 10 levels of prescribed dose, at increments of 10%, from 5 Gy to 50 Gy. By sparing both small bowel and sacral bone, the M2F and M4F plans were significantly better than the C2F and C4F plans at any dose level (p < 0.05), respectively. In addition, the M4F plan was significantly better than the M2F plan in sparing both small bowel at 10-50% of the prescribed dose (p < 0.05) and sacral bone at 40-100% of the prescribed dose (p < 0.05). The present study suggests that modified treatment planning could be useful for selected patients for reducing small bowel complications and insufficiency fracture after radiotherapy.

Entities:  

Mesh:

Year:  2010        PMID: 20972366     DOI: 10.1269/jrr.10046

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  4 in total

1.  Variability in target delineation of cervical carcinoma: A Korean radiation oncology group study (KROG 15-06).

Authors:  Ji Hyeon Joo; Young Seok Kim; Byung Chul Cho; Chi Young Jeong; Won Park; Hak Jae Kim; Won Sup Yoon; Mee Sun Yoon; Ji-Yoon Kim; Jin Hwa Choi; Youngmin Choi; Joo-Young Kim
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

2.  A retrospective study of small-pelvis radiotherapy plus image-guided brachytherapy in stage I-II non-bulky cervical squamous cell carcinoma.

Authors:  Yuya Yoshimoto; Kazutoshi Murata; Daisuke Irie; Ken Ando; Akiko Adachi; Hiroshi Aoki; Takashi Hirakawa; Shin-Ei Noda; Takashi Nakano; Tatsuya Ohno
Journal:  J Radiat Res       Date:  2022-03-17       Impact factor: 2.724

3.  Comparison of hematological toxicities between innovator and generic cisplatin formulations in cervical cancer patients treated with concurrent chemoradiotherapy.

Authors:  Takahiro Oike; Tatsuya Ohno; Shin-ei Noda; Hiro Sato; Tomoaki Tamaki; Hiroki Kiyohara; Ken Ando; Takashi Nakano
Journal:  J Radiat Res       Date:  2012-12-14       Impact factor: 2.724

4.  Distribution patterns of metastatic pelvic lymph nodes assessed by CT/MRI in patients with uterine cervical cancer.

Authors:  Goro Kasuya; Takafumi Toita; Kazuhisa Furutani; Takeshi Kodaira; Tatsuya Ohno; Yuko Kaneyasu; Ryouichi Yoshimura; Takashi Uno; Akira Yogi; Satoshi Ishikura; Masahiro Hiraoka
Journal:  Radiat Oncol       Date:  2013-06-08       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.